1 CONFORMED COPY EXHIBIT 4.1Waiver to Note Purchase Agreement • October 21st, 1996 • Rhodes Inc • Retail-furniture stores • New York
Contract Type FiledOctober 21st, 1996 Company Industry Jurisdiction
WAIVER TO NOTE PURCHASE AGREEMENTWaiver to Note Purchase Agreement • May 16th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
Contract Type FiledMay 16th, 2016 Company IndustryThis WAIVER TO NOTE PURCHASE AGREEMENT dated as of May 16, 2016 (this “Waiver”) to the Note Purchase Agreement (as defined below) is between Omega Pharma N.V., a company incorporated with limited liability in Belgium (the “Company”), and each of the institutions which is a signatory to this Waiver (collectively, the “Noteholders”).
WAIVER NO. 1 TO NOTE PURCHASE AGREEMENTWaiver to Note Purchase Agreement • October 30th, 2012 • Amedisys Inc • Services-home health care services • New York
Contract Type FiledOctober 30th, 2012 Company Industry JurisdictionThis WAIVER NO. 1 TO NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of October 26, 2012 by and among AMEDISYS, INC., a Delaware corporation (the “Company”), and AMEDISYS HOLDING, L.L.C., a Louisiana limited liability company (“Holding”; and together with the Company, the “Issuers”), and the holders of Notes (as defined below) signatory hereto (the “Noteholders”).
SECOND WAIVER TO NOTE PURCHASE AGREEMENTWaiver to Note Purchase Agreement • August 10th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2016 Company IndustryThis SECOND WAIVER TO NOTE PURCHASE AGREEMENT dated as of June 7, 2016 (this “Waiver”) to the Note Purchase Agreement (as defined below) is between Omega Pharma N.V., a company incorporated with limited liability in Belgium (the “Company”), and each of the institutions which is a signatory to this Waiver (collectively, the “Noteholders”).
Re: Waiver to Note Purchase AgreementWaiver to Note Purchase Agreement • August 10th, 2016 • PERRIGO Co PLC • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2016 Company IndustryReference is hereby made to that Waiver to Note Purchase Agreement dated as of May 16, 2016 between Omega Pharma N.V. (the “Company”) and each of the Noteholders party thereto, as the same may be amended, restated, modified or supplemented from time to time (as amended, the "Waiver"). Capitalized terms which are used herein without definition and which are defined in the Waiver shall have the same meanings herein as in the Waiver.
WAIVER TO NOTE PURCHASE AGREEMENTWaiver to Note Purchase Agreement • March 9th, 2016 • Student Transportation Inc. • Local & suburban transit & interurban hwy passenger trans • Illinois
Contract Type FiledMarch 9th, 2016 Company Industry JurisdictionThis WAIVER TO NOTE PURCHASE AGREEMENT (this "Waiver") is dated as of October 21, 2015, among STUDENT TRANSPORTATION OF AMERICA, INC., a Delaware corporation (the "Issuer"), STUDENT TRANSPORTATION OF AMERICA HOLDINGS, INC. ("Holdings"), a Delaware corporation, STUDENT TRANSPORTATION INC. f/k/a STUDENT TRANSPORTATION OF AMERICA LTD. (''Parent"), an Ontario corporation and SUN LIFE ASSURANCE COMPANY OF CANADA, a company governed by the Insurance Companies Act of Canada ("Sun Life"), LONDON LIFE INSURANCE COMPANY, a corporation existing under the Insurance Companies Act of Canada ("London Life"), those persons from time to time entered into the register as holders of the Notes by proper endorsement and delivery (each a "Noteholder” and collectively the "Noteholders") and COMPUTERSHARE TRUST COMPANY, N.A., a national trust company, as trustee (in such capacity, the "Trustee").